(Q43926526)

28 November 2017

title

Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy (English)

1 reference

28 November 2017

1 reference

10

1 reference

28 November 2017

7

Mei Lin Collier

0 references

author name string

Hong-Bo Xin

1

1 reference

28 November 2017

Takaaki Senbonmatsu

2

1 reference

28 November 2017

Dong-Sheng Cheng

3

1 reference

28 November 2017

Yong-Xiao Wang

4

1 reference

28 November 2017

Julio A Copello

5

1 reference

28 November 2017

Guang-Ju Ji

6

1 reference

28 November 2017

Ke-Yu Deng

8

1 reference

28 November 2017

Loice H Jeyakumar

9

1 reference

28 November 2017

Tadashi Inagami

11

1 reference

28 November 2017

Michael I Kotlikoff

12

1 reference

28 November 2017

Sidney Fleischer

13

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

416

1 reference

28 November 2017

issue

6878

1 reference

28 November 2017

page(s)

334-338

1 reference

https://scigraph.springernature.com/pub.10.1038/416334a

28 November 2017

exact match

0 references

cites work

Cellular functions of immunophilins

1 reference

7 January 2021

A Novel FK506 Binding Protein Can Mediate the Immunosuppressive Effects of FK506 and Is Associated with the Cardiac Ryanodine Receptor

1 reference

7 January 2021

Selective binding of FKBP12.6 by the cardiac ryanodine receptor

1 reference

7 January 2021

Three amino acid residues determine selective binding of FK506-binding protein 12.6 to the cardiac ryanodine receptor

1 reference

7 January 2021

Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein

1 reference

7 January 2021

Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12

1 reference

7 January 2021

Biochemistry and biophysics of excitation-contraction coupling

1 reference

7 January 2021

Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors

1 reference

7 January 2021

Characterization of an exchange reaction between soluble FKBP-12 and the FKBP.ryanodine receptor complex. Modulation by FKBP mutants deficient in peptidyl-prolyl isomerase activity.

1 reference

7 January 2021

Different interactions of cardiac and skeletal muscle ryanodine receptors with FK-506 binding protein isoforms

1 reference

7 January 2021

Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex

1 reference

7 January 2021

Inactivation of calcium-activated chloride channels in smooth muscle by calcium/calmodulin-dependent protein kinase

1 reference

7 January 2021

Calcium-induced calcium release in smooth muscle: loose coupling between the action potential and calcium release

1 reference

7 January 2021

Cellular mechanisms of altered contractility in the hypertrophied heart: big hearts, big sparks

1 reference

7 January 2021

Evaluation of ventricular and arterial hemodynamics in anesthetized closed-chest mice

1 reference

7 January 2021

Hypertrophic cardiomyopathy

1 reference

7 January 2021

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

1 reference

7 January 2021

Effect of hormone replacement therapy on left ventricular hypertrophy

1 reference

7 January 2021

Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure

1 reference

7 January 2021

PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts

1 reference

7 January 2021

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

7 January 2021

Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter

1 reference

7 January 2021

1 reference

7 January 2021

Modulation of cardiac hypertrophy by estrogens

1 reference

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

7 January 2021

The roles of gender, the menopause and hormone replacement on cardiovascular function

1 reference

7 January 2021

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1 reference

7 January 2021

Identifiers

DOI

10.1038/416334A

1 reference

Dimensions Publication ID

28 November 2017

1044156002

0 references

1 reference